RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 15.65
+0.70 (4.68%)
Apr 1, 2026, 12:00 PM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 203.07 million as of April 1, 2026. Its market cap has decreased by -20.15% in one year.
Market Cap
203.07M
Enterprise Value
578.68M
Revenue
201.85M
Ranking
n/a
PE Ratio
11.47
Stock Price
15.65
Market Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 203.07M, a decrease of -67.88%. That is a compound annual growth rate of -22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 203.07M | -7.12% |
| Dec 31, 2025 | 218.65M | -11.78% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 935.35M |
| TCI GENE | 923.40M |
| Taiwan Advance Bio-Pharmaceutical | 918.00M |
| Neith | 899.73M |
| BioLASCO Taiwan | 742.75M |
| SynCore Biotechnology Co.,Ltd | 719.12M |
| TaiwanJ Pharmaceuticals | 602.52M |
| Vectorite Biomedical | 538.39M |